CNL and aCML should be considered as single entity based on molecular profiles and outcomes by Carreño-Tarragona, G, Alvarez-Larran, A, Harrison, CN, Martínez-Ávila, JC, Hernandez-Boluda, JC, Ferrer-Marin, F, Radia, DH, Mora Casterá, E, Francis, S, González-Martínez, T, Goddard, K, Perez-Encinas, M, Narayanan, S, Raya, JM, Singh, V, Toth, P, Gutiérrez, X, Amat Martinez, P, McIlwaine, L, Alobaidi, M, Mayani, K, McGregor, A, Stuckey, R, Psaila, B, Segura, A, Alvares, CL, Davidson, K, Osorio, S, Cutting, R, Sweeney, CP, Rufian, L, Moreno, L, Cuenca, I, Smith, J, Morales, ML, Gil-Manso, R, Koutsavlis, I, Wang, L, Mead, AJ, Rozman, M, Martínez-López, J, Ayala, R, Cross, NC